These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9872608)

  • 1. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure.
    Garg RK; Gheorghiade M; Jafri SM
    Prog Cardiovasc Dis; 1998; 41(3):225-36. PubMed ID: 9872608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic therapy for heart failure in sinus rhythm.
    Subramaniam V; Davis RC; Shantsila E; Lip GY
    Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolism in heart failure: who should be treated?
    Diet F; Erdmann E
    Eur J Heart Fail; 2000 Dec; 2(4):355-63. PubMed ID: 11113711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolism and antithrombotic therapy in congestive heart failure.
    Dunkman WB
    J Cardiovasc Risk; 1995 Apr; 2(2):107-17. PubMed ID: 7606647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
    Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P
    Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction.
    Baker DW; Wright RF
    JAMA; 1994 Nov 23-30; 272(20):1614-8. PubMed ID: 7966873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do anticoagulants or antiplatelet drugs have a role in treating heart failure in the absence of atrial fibrillation?
    Gouda P; Ezekowitz JA
    Clin Pharmacol Ther; 2013 Oct; 94(4):435-8. PubMed ID: 24048238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2016 May; (5):CD003333. PubMed ID: 27140950
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients.
    Cioffi G; Pozzoli M; Forni G; Franchini M; Opasich C; Cobelli F; Tavazzi L
    Eur Heart J; 1996 Sep; 17(9):1381-9. PubMed ID: 8880024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction.
    Thatai D; Ahooja V; Pullicino PM
    Am J Cardiovasc Drugs; 2006; 6(1):41-9. PubMed ID: 16489847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboembolism in Heart Failure Patients in Sinus Rhythm: Epidemiology, Pathophysiology, Clinical Trials, and Future Direction.
    Lin AY; Dinatolo E; Metra M; Sbolli M; Dasseni N; Butler J; Greenberg BH
    JACC Heart Fail; 2021 Apr; 9(4):243-253. PubMed ID: 33714744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant and antiplatelet therapy in heart failure.
    Cleland JG
    Curr Opin Cardiol; 1997 May; 12(3):276-87. PubMed ID: 9243085
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis.
    Rengo G; Pagano G; Squizzato A; Moja L; Femminella GD; de Lucia C; Komici K; Parisi V; Savarese G; Ferrara N; Perrone-Filardi P; Leosco D
    PLoS One; 2013; 8(1):e52952. PubMed ID: 23301006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation in Patients with Heart Failure and Sinus Rhythm.
    Li X; Yang J; Xu D
    Int Heart J; 2020 Nov; 61(6):1204-1211. PubMed ID: 33191346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic Therapy for Heart Failure in Sinus Rhythm - A Concise Review.
    Sharma R; Subedi A
    S D Med; 2024 May; 77(5):213-219. PubMed ID: 39012774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
    Prom R; Usedom JE; Dull RB
    Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.